Both in Biotechnology
TScan Therapeutics vs Scilex Holding
Over the past year TCRX returned −81.3% and SCLX returned −90.7%; their daily moves had a correlation of 0.20.
TCRX −81.3% SCLX −90.7%Growth of $1, one year, split-adjusted
| Metric | TCRX | SCLX |
|---|---|---|
| Price | $0.2100 | $1.83 |
| Market cap | $14.2M | $12.9M |
| Today | +11.11% | −1.08% |
| 1 month | −23.7% | −53.8% |
| 6 months | −83.2% | −80.7% |
| Year to date | −79.0% | −85.0% |
| 1 year | −83.1% | −89.8% |
| Revenue growth (YoY) | −65.8% | −22.8% |
| Gross margin | 100.0% | 51.9% |
| Net margin | −2888.6% | −1501.3% |
| P/E (TTM) | — | — |
| Price / sales | 2.0× | 0.4× |
| Net cash | $67.4M | -$82.5M |
| Dividend yield | — | — |
| Volatility (60d) | 143.0% | 70.2% |
| Short % of float | 4.1% | 2.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).